A. Bommireddy

Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose

D. Ludwig, L. Henke, N. Maughan, 2022, Advances in radiation oncology.

Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma cells and preclinical models.

Amy Li, J. Reiter, D. Raleigh, 2021, The Journal of clinical investigation.

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation

Justin C. Park, R. Fields, M. Roach, 2020, Advances in radiation oncology.

DDRE-02. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA

Amy Li, J. Reiter, D. Raleigh, 2020, Neuro-oncology Advances.

Fragmented Care in the Treatment of Rectal Cancer and Time to Definitive Therapy.

W. Chapman, M. Mutch, S. Hunt, 2020, Journal of the American College of Surgeons.

Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience

P. Parikh, N. Andruska, L. Henke, 2023, Clinical and translational radiation oncology.